Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • ACE2

Tag: ACE2

  • BiotechToday
  • World

Concern for Structural Changes in Covid19 variants

DNA tales July 3, 2021July 2, 2021

Sribas Chowdhury, Adamas University Kolkata We all know how the horrific Covid19 pandemic has shaken the entire world. With the SARS-corona virus, 2 is the main culprit, it has claimed millions of lives worldwide and has disrupted the socio-economic balance of all countries. The virus has been a cause of concern due to its variants […]

Read More
  • BiotechToday
  • World

Alzheimer’s-like dementia due to Covid

BioTech Today June 17, 2021June 16, 2021 1

Souradip Mallick, National Institute of Technology, Rourkela In the last two decades, various coronavirus diseases have become a major public health issue, starting with the SARS-CoV pandemic in 2002 through 2003, then the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in 2012, and current the COVID-19 pandemic. In all the cases, it has been reported […]

Read More
  • BiotechToday
  • World

Aptamer: A novel active ingredient to fight Coronavirus

bioxone April 22, 2021April 22, 2021 1

Devyani Goswami, Amity University Kolkata Since the identification of the SARS-CoV-2 virus, the spike protein of it has been a topic of great interest among researchers. These spike proteins are capable of infecting the host cells after their attachment to the ACE2 receptor binding domain. The new mutated strains have caused a huge amount of […]

Read More
  • BiotechToday
  • World

AXL receptor: a new companion of the ACE2 receptor which helps SARS-CoV-2 to enter the human body

bioxone January 16, 2021January 16, 2021 1

Parnad Basu, Amity University Kolkata The pandemic caused by COVID-19 is continuing still. The causative viral pathogen of COVID-19 is SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This SARS-CoV-2 actually belongs to the β coronavirus genus along with SARS-CoV (severe acute respiratory syndrome coronavirus) and MERS-CoV (middle east respiratory syndrome coronavirus). Although SARS-CoV-2 targets the […]

Read More
  • BiotechToday
  • World

Why COVID-19 infects only some animals and not others?

bioxone December 23, 2020December 23, 2020 1

Anannya Roy, Amity University Kolkata 3-Dimensional modeling of Protein structure can provide us with lots of insights on its functions and interactions. Researchers from Stanford University, California utilized this technique to study the receptor-binding domain of SARS-coV-2. This discovery could help in drug development and the prediction of future outbreaks. Coronavirus disease (COVID-19) has changed […]

Read More
  • BiotechToday
  • World

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020 1

Anwesha Chatterjee, Amity University Kolkata The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection […]

Read More
  • Biotechnopedia
  • DNA-Tales

Role of Angiotensin receptor blockers towards COVID-19

bioxone September 27, 2020September 27, 2020

Debraj Ghosh, Undergraduate student of Medicinal Institute, People’s Friendship Institute of Russia, Moscow, Russia Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(1) is the strain of coronavirus causes the respiratory illness responsible for the COVID-19 pandemic. It is a positive ssRNA(4) virus that is contagious to humans and is a successor to SARS-CoV-1 according to the U.S. National Institute of Health. The SARS-CoV-2 virion […]

Read More
  • India

COVID UPDATE: Indian genes against the coronavirus

bioxone September 18, 2020September 18, 2020

-Binayak Das, Team bioXone A team of scientists claims that Indians should be grateful to their genetics, which according to their study is a critical factor in having a comparatively lesser number of deaths from COVID-19 in their populations. They studied the complete DNA data of the ACE2 gene in the X chromosomes from different […]

Read More
  • World

Heparin sulfate: the key to coronavirus infection

bioxone September 18, 2020September 18, 2020

-Arpita Adhikary, Amity University Kolkata It has been observed in the studies that when the SARS-CoV-2 virus infects – Heparin sulfate and ACE2 enter inside the cells. The course of viral entry and successful attachment is quite limpid. Angiotensin-converting enzyme 2 receptors are present on the outer surface of cells that line the lungs. SARS-CoV-2 […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COMPUTER DESIGNED SYNTHETIC ANTIVIRAL PROTEINS INHIBIT SARS-COV 2/COVID 19 IN HUMAN CELLS

bioxone September 15, 2020September 15, 2020

–Rishav Chakraborty, Calcutta National Medical College, Kolkata The SARS-COV infection occurred first in 2003-2004. The infection is believed to be contracted from animals including monkeys, Himalayan palm civets, cats, dogs, and rodents. Clinical manifestation including myalgia, headache, sore throat, and fever followed by severe respiratory distress. The virus binds with the ACE-2 (Angiotensinogen Converting Enzyme) […]

Read More

Posts navigation

1 2

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy